CANADA
Canadian market access and commercialisation
Plan Health Canada registration and reimbursement pathways against Canadian regulatory and commercial conditions, while developing pharmaceutical channels, local partnerships and execution resources.
MARKET PERSPECTIVE
The same commercial objective,
a pathway suited to Canada.
Canadian work currently focuses on pathway planning and developing partner resources. Clinical, licensing, reimbursement, warehousing and delivery needs are assessed against local rules and available resources, with execution scope confirmed for each project.
Canadian business support
Canadian medical device registration: MDL / MDEL
Distinguish device from establishment licensing, then assess MDSAP, product evidence, labels and import arrangements. Explore preparation checklists, stage deliverables and engagement scope for Canada.
04Canadian market and channel development
Screen Canadian channels against target customers, licensed entities, pricing and delivery conditions. Explore partner checks, commercial materials, pilot development and stage deliverables.
HOW WE WORK
Clarify the next step for your project stage.
Define the product
Clarify use, users, technology and documentation, distinguishing medical devices, medicines and natural health products first.
Separate licensing responsibilities
Check product licensing and import/distribution activity requirements and identify the proposed responsible entities.
Validate channel assumptions
Choose provinces and customer types and verify prospective partners' authorizations, coverage and procurement conditions.
Decide the next investment
Use document gaps and channel feedback to decide whether to develop evidence, prepare an application or validate commercial assumptions first.
Discuss your product registration project
Provide intended use, existing authorizations and launch plans so we can assess preparation and support needs.